Surotomycin is an investigational oral antibiotic, belonging to the cyclic lipopeptide class, that was developed for the treatment of life-threatening diarrhea caused by Clostridium difficile infections.… Read more
Surotomycin is an investigational oral antibiotic, belonging to the cyclic lipopeptide class, that was developed for the treatment of life-threatening diarrhea caused by Clostridium difficile infections. This category features a comprehensive range of high-quality analytical tools necessary for rigorous pharmaceutical research, including Surotomycin reference standards, along with its pharmacopeial and non-pharmacopeial impurities. Laboratories utilize these compounds for critical analytical testing, such as impurity profiling, ensuring compliance with established regulatory specifications. Additionally, the availability of stable isotope labelled compounds and metabolites supports advanced method validation and quantitative analysis, allowing researchers to accurately monitor drug degradation and metabolic pathways. By providing these specific materials, the collection facilitates precise quality control and development processes essential for the characterization of this antibiotic agent in controlled environments.